The ability of 2-deoxy-d-glucose (2-DG) to interfere with d-glucose metabolism demonstrates
that nutrient and energy deprivation is an efficient tool to suppress cancer cell growth and …

Sonodynamic therapy (SDT) represents a promising modality that provides the possibility of
non-invasively eliminating solid tumors in a site-directed manner. In light of the complexity …

Cancer is an abnormal condition leading to uncontrolled cell division which causes damage
to the body tissues. Around 100 types of cancer are studied so far namely breast cancer …

Non-genetic mechanisms have recently emerged as important drivers of anticancer drug
resistance. Among these, the drug tolerant persister (DTP) cell phenotype is attracting more …

It is well established that cancer cells depend upon aerobic glycolysis to provide the energy
they need to survive and proliferate. However, anti‐glycolytic agents have yielded few …

Chloroethylnitrosoureas (CENUs) exert antitumor activity via producing dG-dC interstrand
crosslinks (ICLs). However, tumor resistance make it necessary to find novel strategies to …

The nonmetabolizable glucose analog 2‐deoxy‐D‐glucose (2‐DG) has shown promising
pharmacological activities, including inhibition of cancerous cell growth and N …

Cervical cancer is one of the most common female malignant tumors, with typical cancer
metabolism characteristics of increased glycolysis flux and lactate accumulation. 2‐Deoxy‐D …

Metastasis is a major dilemma of cancer therapy. It frequently occurs in breast cancer, which
is the leading form of malignant tumor among females worldwide. Although there are …

Multi-targeted approaches for inhibition of сervical cancer cells in vitro were developed by
implementing two different strategies and drug combination for creation of new therapeutic …